ID: ALA4287053

Max Phase: Preclinical

Molecular Formula: C14H24N2O3

Molecular Weight: 268.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC12CC3CC(N)(C1)CC(CCCO[N+](=O)[O-])(C3)C2

Standard InChI:  InChI=1S/C14H24N2O3/c1-12-5-11-6-13(8-12,3-2-4-19-16(17)18)10-14(15,7-11)9-12/h11H,2-10,15H2,1H3

Standard InChI Key:  VXTOKMAJQLRIAA-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 268.36Molecular Weight (Monoisotopic): 268.1787AlogP: 2.66#Rotatable Bonds: 5
Polar Surface Area: 78.39Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.70CX LogP: 2.22CX LogD: -0.63
Aromatic Rings: 0Heavy Atoms: 19QED Weighted: 0.47Np Likeness Score: 0.18

References

1. Liu Z, Yang S, Jin X, Zhang G, Guo B, Chen H, Yu P, Sun Y, Zhang Z, Wang Y..  (2017)  Synthesis and biological evaluation of memantine nitrates as a potential treatment for neurodegenerative diseases.,  (1): [PMID:30108699] [10.1039/C6MD00509H]

Source